B&K Corporation Limited
Status: Publicly traded
Direct answer
B&K Corporation Limited is publicly traded on HKSE under the ticker 2396.HK.
B&K Corporation Limited operates as a biopharmaceutical company developing therapies with an emphasis on protein drugs for indications with medical needs and market opportunities in China. The company primarily focuses on the discovery, development, and commercialization of therapies for wound healing, currently platelet-derived growth factor (PDGF) drugs. The company's pipeline comprised two Core Products...
Can you invest in B&K Corporation Limited?
Yes. B&K Corporation Limited trades publicly on HKSE as 2396.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for B&K Corporation Limited
Detailed equity research is provided by MarketSnap.